Literature DB >> 26661829

The Lipidomic Analyses in Low and Highly Aggressive Ovarian Cancer Cell Lines.

Zhenwen Zhao1, Qingchun Cai2, Yan Xu3.   

Abstract

Despite huge advances in the research of epithelial ovarian cancer (EOC), it remains the most lethal gynecological malignancy. Peritoneal tumor cell dissemination with cell survival and drug-resistance to taxane and platinum-based chemotherapy are two of the major challenges of EOC treatment. We have generated highly aggressive EOC cell lines (ID8-P1 lines or P1) from ID8-P0 (without in vivo passage, or P0) through in vivo passage in mice. We conducted lipidomic analyses in cells from ID8-P0 versus three ID8-P1 cell lines using ultra-high-performance liquid chromatography coupled to electrospray ionization tandem mass spectrometry. A total of 16 classes of lipids (149 individual lipids) were analyzed and compared between P0 and P1 cells. In addition to overall lipid profiles in EOC cells, we had several novel observations. Several classes and species of lipids have been identified to be differentially present in P0 versus P1 cells, which are potentially involved in the acquired aggressiveness of P1 cells. Triacylglycerols (TAG) were dramatically increased under detachment stress in EOC cells. Since survival of EOC cells under detachment is one of the major obstacles for EOC treatment, further studies identifying the molecular mechanisms controlling TAG increase may lead to new treatment modalities for EOC.

Entities:  

Keywords:  Electrospray ionization-mass spectrometry (ESI-MS); Epithelial ovarian cancer (EOC); ID8; Lipidomic analyses; Triacylglycerol (TAG)

Mesh:

Substances:

Year:  2015        PMID: 26661829     DOI: 10.1007/s11745-015-4108-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  26 in total

1.  Lipidomics: new tools and applications.

Authors:  Markus R Wenk
Journal:  Cell       Date:  2010-12-10       Impact factor: 41.582

2.  Secretion of vascular endothelial growth factor in ovarian cancer.

Authors:  A D Santin; P L Hermonat; A Ravaggi; M J Cannon; S Pecorelli; G P Parham
Journal:  Eur J Gynaecol Oncol       Date:  1999       Impact factor: 0.196

3.  Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity.

Authors:  M T Speidel; F M Booyse; A Abrams; M A Moore; B H Chung
Journal:  Thromb Res       Date:  1990-05-01       Impact factor: 3.944

4.  -Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma-.

Authors:  J Radke; D Schmidt; M Böhme; U Schmidt; W Weise; J Morenz
Journal:  Geburtshilfe Frauenheilkd       Date:  1996-02       Impact factor: 2.915

5.  An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples.

Authors:  Zhenwen Zhao; Yan Xu
Journal:  J Lipid Res       Date:  2009-09-25       Impact factor: 5.922

6.  Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.

Authors:  Ardian Latifi; Rodney B Luwor; Maree Bilandzic; Simon Nazaretian; Kaye Stenvers; Jan Pyman; Hongjian Zhu; Erik W Thompson; Michael A Quinn; Jock K Findlay; Nuzhat Ahmed
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

7.  Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism.

Authors:  Jianqun Liao; Feng Qian; Nana Tchabo; Paulette Mhawech-Fauceglia; Amy Beck; Zikun Qian; Xinhui Wang; Wendy J Huss; Shashikant B Lele; Carl D Morrison; Kunle Odunsi
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

Review 8.  Lipid metabolism, apoptosis and cancer therapy.

Authors:  Chunfa Huang; Carl Freter
Journal:  Int J Mol Sci       Date:  2015-01-02       Impact factor: 5.923

9.  The microenvironment reprograms circuits in tumor cells.

Authors:  Qingchun Cai; Yan Xu
Journal:  Mol Cell Oncol       Date:  2015-01-28
View more
  7 in total

Review 1.  Advances in Lipidomics for Cancer Biomarkers Discovery.

Authors:  Francesca Perrotti; Consuelo Rosa; Ilaria Cicalini; Paolo Sacchetta; Piero Del Boccio; Domenico Genovesi; Damiana Pieragostino
Journal:  Int J Mol Sci       Date:  2016-11-28       Impact factor: 5.923

2.  A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency.

Authors:  Arun Kumar Tharkeshwar; Jesse Trekker; Wendy Vermeire; Jarne Pauwels; Ragna Sannerud; David A Priestman; Danielle Te Vruchte; Katlijn Vints; Pieter Baatsen; Jean-Paul Decuypere; Huiqi Lu; Shaun Martin; Peter Vangheluwe; Johannes V Swinnen; Liesbet Lagae; Francis Impens; Frances M Platt; Kris Gevaert; Wim Annaert
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

3.  Changes in mRNA/protein expression and signaling pathways in in vivo passaged mouse ovarian cancer cells.

Authors:  Qingchun Cai; Qipeng Fan; Aaron Buechlein; David Miller; Kenneth P Nephew; Sheng Liu; Jun Wan; Yan Xu
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

Review 4.  Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2018-07-09       Impact factor: 6.639

5.  Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer.

Authors:  Feikai Lin; Xiaoduan Li; Xinjing Wang; Huizhen Sun; Ziliang Wang; Xipeng Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-04-07

6.  Prolactin and Risk of Epithelial Ovarian Cancer.

Authors:  Cassandra A Hathaway; Megan S Rice; Mary K Townsend; Susan E Hankinson; Alan A Arslan; Julie E Buring; Göran Hallmans; Annika Idahl; Laura D Kubzansky; I-Min Lee; Eva A Lundin; Patrick M Sluss; Anne Zeleniuch-Jacquotte; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-08       Impact factor: 4.254

7.  Ovarian tumours of different histologic type and clinical stage induce similar changes in lipid metabolism.

Authors:  Riikka Johanna Niemi; Elena Ioana Braicu; Hagen Kulbe; Kaisa Maria Koistinen; Jalid Sehouli; Ulla Puistola; Johanna Unelma Mäenpää; Mika Hilvo
Journal:  Br J Cancer       Date:  2018-10-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.